C095 | IMPACT OF IGHV REPERTOIRE AFTER IBRUTINIB-CONTAINING REGIMENS IN YOUNGER UNTREATED MANTLE CELL LYMPHOMA PATIENTS: AN ANALYSIS OF THE TRIANGLE DATA EMBEDDED IN THE MULTIPLY PROJECT

Introduction: The TRIANGLE trial (Dreyling et al. 2024) compared three treatment arms (arm I: IR-CHOP/R-DHAP+ ibrutinib maintenance (Im); arm A+I: IR-CHOP/ R-DHAP + ASCT +Im; arm A: previous standard of care R-CHOP/ R-DHAP + ASCT) for younger, untreated mantle cell lymphoma (MCL) patients (pts), de...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	S. Ragaini, R. Moia, K. Gutmair, M. Khouja, E. Genuardi, J. Nabki, P. Nakov, D. Drandi, C.H.E. Homburg, R. García-Sanz, P. Gameiro, E. Froňková, B. Schaefer, C. Montana, B. Al Deeban, S. Stilgenbauer, C.U. Niemann, M. Celli, J. Doorduijn, G. Gaidano, E. Giné, M. Gomes Da Silva, P. Klener, M. Jerkeman, U. Mey, E. Hoster, A. Evangelista, S. Beà, M. Dreyling, C. Pott, M. Ladetto, S. Ferrero
Format:	Artigo
Sprog:	Inglês
Udgivet:	Ferrata Storti Foundation 2025-09-01
Serier:	Haematologica
Online adgang:	https://haematologica.org/article/view/12759
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!